Home / Denmark / Novozymes A/S
Novozymes A/S
Short position disclosed on July 28, 2026.
Evolution of the disclosed total
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 0.79% | new | July 28, 2026 |
In the United States NVZMF (OTC): 881,571 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Novozymes A/S Titelia
Get the moves on Novozymes A/S by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 8, 2023 | Davidson Kempner European Partners, LLP | 1.37% | May 8, 2023 |
| May 4, 2023 | Davidson Kempner European Partners, LLP | 1.28% | May 4, 2023 |
| May 3, 2023 | Davidson Kempner European Partners, LLP | 1.11% | May 3, 2023 |
| April 28, 2023 | UBS O'Connor LLC | 0.51% | April 28, 2023 |
| April 18, 2023 | Davidson Kempner European Partners, LLP | 1.02% | April 18, 2023 |
| April 18, 2023 | Citadel Advisors Europe Limited | 0.50% | April 18, 2023 |
| April 14, 2023 | D. E. Shaw & Co. (London), LLP | 0.64% | April 14, 2023 |
| April 12, 2023 | Marshall Wace LLP | 0.46% | April 12, 2023 |
| April 5, 2023 | D. E. Shaw & Co. (London), LLP | 0.53% | April 5, 2023 |
| March 28, 2023 | Davidson Kempner European Partners, LLP | 0.95% | March 28, 2023 |
| March 17, 2023 | Davidson Kempner European Partners, LLP | 0.89% | March 17, 2023 |
| March 3, 2023 | Davidson Kempner European Partners, LLP | 0.93% | March 3, 2023 |
| February 23, 2023 | Marshall Wace LLP | 0.52% | February 23, 2023 |
| February 16, 2023 | AQR Capital Management, LLC | 0.70% | February 16, 2023 |
| February 1, 2023 | Davidson Kempner European Partners, LLP | 0.85% | February 1, 2023 |
| January 31, 2023 | Davidson Kempner European Partners, LLP | 0.73% | January 31, 2023 |
| January 30, 2023 | AQR Capital Management, LLC | 0.60% | January 30, 2023 |
| January 25, 2023 | Davidson Kempner European Partners, LLP | 0.61% | January 25, 2023 |
| January 24, 2023 | Davidson Kempner European Partners, LLP | 0.51% | January 24, 2023 |
| January 19, 2023 | AQR Capital Management, LLC | 0.57% | January 19, 2023 |
| January 18, 2023 | AQR Capital Management, LLC | 0.60% | January 18, 2023 |
| December 19, 2022 | AQR Capital Management, LLC | 0.51% | December 19, 2022 |
| December 14, 2022 | Magnetar Financial LLC | 0.60% | December 14, 2022 |
| December 8, 2021 | Citadel Europe LLP | 0.48% | December 8, 2021 |
| October 27, 2021 | Citadel Europe LLP | 0.50% | October 27, 2021 |
| April 27, 2021 | Marshall Wace LLP | 0.45% | April 27, 2021 |
| March 3, 2021 | Marshall Wace LLP | 0.51% | March 3, 2021 |
| November 10, 2020 | Marshall Wace LLP | 0.49% | November 10, 2020 |
| November 4, 2020 | Marshall Wace LLP | 0.50% | November 4, 2020 |
| October 22, 2020 | Marshall Wace LLP | 0.49% | October 22, 2020 |
| October 7, 2020 | Marshall Wace LLP | 0.50% | October 7, 2020 |
| April 7, 2020 | Marshall Wace LLP | 0.47% | April 7, 2020 |
| March 26, 2020 | Marshall Wace LLP | 0.56% | March 26, 2020 |
| March 25, 2020 | Marshall Wace LLP | 0.63% | March 25, 2020 |
| March 12, 2020 | Marshall Wace LLP | 0.70% | March 12, 2020 |
| March 3, 2020 | Marshall Wace LLP | 0.61% | March 3, 2020 |
| February 25, 2020 | Marshall Wace LLP | 0.51% | February 25, 2020 |
| January 7, 2020 | Marshall Wace LLP | 0.47% | January 7, 2020 |
| January 6, 2020 | Marshall Wace LLP | 0.58% | January 6, 2020 |
| December 10, 2019 | Marshall Wace LLP | 0.69% | December 10, 2019 |
| November 26, 2019 | Marshall Wace LLP | 0.70% | November 26, 2019 |
| November 20, 2019 | Marshall Wace LLP | 0.68% | November 20, 2019 |
| November 18, 2019 | Marshall Wace LLP | 0.71% | November 18, 2019 |
| November 13, 2019 | Marshall Wace LLP | 0.69% | November 13, 2019 |
| October 25, 2019 | Marshall Wace LLP | 0.78% | October 25, 2019 |
| October 21, 2019 | Marshall Wace LLP | 0.80% | October 21, 2019 |
| October 10, 2019 | Marshall Wace LLP | 0.76% | October 10, 2019 |
| October 3, 2019 | Marshall Wace LLP | 0.80% | October 3, 2019 |
| September 2, 2019 | Marshall Wace LLP | 0.79% | September 2, 2019 |
| August 8, 2019 | Marshall Wace LLP | 0.88% | August 8, 2019 |
Download 225 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Denmark
- Zealand Pharma A/S 6.33% of the capital sold short
- GN Store Nord A/S 5.56% of the capital sold short
- Netcompany Group A/S 4.49% of the capital sold short
- Ambu A/S 2.58% of the capital sold short
- Pandora A/S 1.89% of the capital sold short
- Carlsberg A/S 1.44% of the capital sold short
- Bavarian Nordic A/S 1.29% of the capital sold short
- Matas A/S 1.08% of the capital sold short
- A.P. Møller - Mærsk A/S 1.04% of the capital sold short
- Coloplast A/S 1.01% of the capital sold short
- Vestas Wind Systems A/S 1.01% of the capital sold short
- Rockwool A/S 1.00% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novozymes A/S, source Finanstilsynet, data as at July 28, 2026, https://www.quivad.com/action/novozymes-a-s?page=3